Login
Home
Charts
Search
Watchlist
Products

Ganesh Benzoplast Ltd

GANESHBE·NSE
131.00+4.62%Wed, 23 Sept '26 13:35

Ganesh Benzoplast Ltd

GANESHBE
NSE
131.00
+4.62%
|Wed, 23 Sept '26 13:35
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
943Cr
Close
Close Price
131.00
Industry
Industry
Chemicals - Inorganic
PE
Price To Earnings
12.97
PS
Price To Sales
2.18
Revenue
Revenue
433Cr
Rev Gr TTM
Revenue Growth TTM
13.31%
PAT Gr TTM
PAT Growth TTM
82.91%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
1031061468898891009699105111118
Growth YoY
Revenue Growth YoY%
7.17.39.1-28.2-4.9-16.0-31.79.21.418.111.622.9
Expenses
ExpensesCr
7782125627362686777839191
Operating Profit
Operating ProfitCr
252421252527322922222127
OPM
OPM%
24.722.714.428.725.130.331.630.422.220.818.423.0
Other Income
Other IncomeCr
227454-40417855
Interest Expense
Interest ExpenseCr
101121221112
Depreciation
DepreciationCr
556666666666
PBT
PBTCr
212121222224-162532221924
Tax
TaxCr
657656-378636
PAT
PATCr
161614161618-131824161518
Growth YoY
PAT Growth YoY%
15.310.8-3.16.15.714.4-192.310.344.4-12.2215.9-3.0
NPM
NPM%
15.215.19.818.816.920.6-13.219.024.015.313.715.0
EPS
EPS
2.32.32.02.32.32.5-1.82.53.32.22.12.4
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
1031061468898891009699105111118
Growth YoY
Revenue Growth YoY%
7.17.39.1-28.2-4.9-16.0-31.79.21.418.111.622.9
Expenses
ExpensesCr
7782125627362686777839191
Operating Profit
Operating ProfitCr
252421252527322922222127
OPM
OPM%
24.722.714.428.725.130.331.630.422.220.818.423.0
Other Income
Other IncomeCr
227454-40417855
Interest Expense
Interest ExpenseCr
101121221112
Depreciation
DepreciationCr
556666666666
PBT
PBTCr
212121222224-162532221924
Tax
TaxCr
657656-378636
PAT
PATCr
161614161618-131824161518
Growth YoY
PAT Growth YoY%
15.310.8-3.16.15.714.4-192.310.344.4-12.2215.9-3.0
NPM
NPM%
15.215.19.818.816.920.6-13.219.024.015.313.715.0
EPS
EPS
2.32.32.02.32.32.5-1.82.53.32.22.12.4

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
169212247270358421477374411433
Growth
Revenue Growth%
25.116.69.632.217.713.4-21.59.913.3
Expenses
ExpensesCr
117156183191296333382266318342
Operating Profit
Operating ProfitCr
525663796188961089491
OPM
OPM%
30.626.525.629.417.120.820.028.922.721.1
Other Income
Other IncomeCr
52-2-7-42813-273435
Interest Expense
Interest ExpenseCr
111097445765
Depreciation
DepreciationCr
12121315151720222424
PBT
PBTCr
81313453457484529897
Tax
TaxCr
00032121923142524
PAT
PATCr
81313422335561387373
Growth
PAT Growth%
-61.37.6-35.049.468.511.6-38.092.582.9
NPM
NPM%
47.714.813.68.19.113.112.910.217.816.8
EPS
EPS
15.66.06.55.05.48.89.15.310.210.1
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
169212247270358421477374411433
Growth
Revenue Growth%
25.116.69.632.217.713.4-21.59.913.3
Expenses
ExpensesCr
117156183191296333382266318342
Operating Profit
Operating ProfitCr
525663796188961089491
OPM
OPM%
30.626.525.629.417.120.820.028.922.721.1
Other Income
Other IncomeCr
52-2-7-42813-273435
Interest Expense
Interest ExpenseCr
111097445765
Depreciation
DepreciationCr
12121315151720222424
PBT
PBTCr
81313453457484529897
Tax
TaxCr
00032121923142524
PAT
PATCr
81313422335561387373
Growth
PAT Growth%
-61.37.6-35.049.468.511.6-38.092.582.9
NPM
NPM%
47.714.813.68.19.113.112.910.217.816.8
EPS
EPS
15.66.06.55.05.48.89.15.310.210.1

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
666667777
Reserves
ReservesCr
75106140226259342494531604
Current Liabilities
Current LiabilitiesCr
909379807397101105148
Non Current Liabilities
Non Current LiabilitiesCr
684646613975687484
Total Liabilities
Total LiabilitiesCr
239251271378398533677724850
Current Assets
Current AssetsCr
686883118115151203226244
Non Current Assets
Non Current AssetsCr
170183187260283382473497606
Total Assets
Total AssetsCr
239251271378398533677724850
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
666667777
Reserves
ReservesCr
75106140226259342494531604
Current Liabilities
Current LiabilitiesCr
909379807397101105148
Non Current Liabilities
Non Current LiabilitiesCr
684646613975687484
Total Liabilities
Total LiabilitiesCr
239251271378398533677724850
Current Assets
Current AssetsCr
686883118115151203226244
Non Current Assets
Non Current AssetsCr
170183187260283382473497606
Total Assets
Total AssetsCr
239251271378398533677724850

Cash Flow

Consolidated
Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
396027578641835579
Investing Cash Flow
Investing Cash FlowCr
-19-27-13-40-59-62-147-60-79
Financing Cash Flow
Financing Cash FlowCr
-21-30-14-9-251573-1-2
Net Cash Flow
Net Cash FlowCr
-13072-710-6-1
Free Cash Flow
Free Cash FlowCr
2032134366-3116
CFO To PAT
CFO To PAT%
48.8193.178.8258.8263.773.7135.5144.3108.1
CFO To EBITDA
CFO To EBITDA%
76.1107.642.071.3140.746.387.150.784.7
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
396027578641835579
Investing Cash Flow
Investing Cash FlowCr
-19-27-13-40-59-62-147-60-79
Financing Cash Flow
Financing Cash FlowCr
-21-30-14-9-251573-1-2
Net Cash Flow
Net Cash FlowCr
-13072-710-6-1
Free Cash Flow
Free Cash FlowCr
2032134366-3116
CFO To PAT
CFO To PAT%
48.8193.178.8258.8263.773.7135.5144.3108.1
CFO To EBITDA
CFO To EBITDA%
76.1107.642.071.3140.746.387.150.784.7

Ratios

Consolidated
Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
4262471213886381,0581,323756517943
Price To Earnings
Price To Earnings
5.88.74.017.719.519.221.520.27.113.0
Price To Sales
Price To Sales
2.51.20.51.41.82.52.82.01.32.2
Price To Book
Price To Book
5.82.40.91.72.43.02.61.40.81.5
EV To EBITDA
EV To EBITDA
9.55.12.55.210.112.413.46.75.59.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
46.042.150.048.537.739.441.148.348.548.5
OPM
OPM%
30.626.525.629.417.120.820.028.922.721.1
NPM
NPM%
47.714.813.68.19.113.112.910.217.816.8
ROCE
ROCE%
63.226.722.920.616.819.115.99.815.115.1
ROE
ROE%
100.027.923.19.412.315.812.37.112.012.0
ROA
ROA%
33.812.512.45.88.210.39.15.38.68.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
4262471213886381,0581,323756517943
Price To Earnings
Price To Earnings
5.88.74.017.719.519.221.520.27.113.0
Price To Sales
Price To Sales
2.51.20.51.41.82.52.82.01.32.2
Price To Book
Price To Book
5.82.40.91.72.43.02.61.40.81.5
EV To EBITDA
EV To EBITDA
9.55.12.55.210.112.413.46.75.59.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
46.042.150.048.537.739.441.148.348.548.5
OPM
OPM%
30.626.525.629.417.120.820.028.922.721.1
NPM
NPM%
47.714.813.68.19.113.112.910.217.816.8
ROCE
ROCE%
63.226.722.920.616.819.115.99.815.115.1
ROE
ROE%
100.027.923.19.412.315.812.37.112.012.0
ROA
ROA%
33.812.512.45.88.210.39.15.38.68.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Ganesh Benzoplast Ltd

  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/3q5m7ug5l7pgdg9otdc7xvgm.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/0mmwh22kqdygfmo6picojly4.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/5whvq86ja57bcf1t1zyu2xjg.pdf
  • Q3 FY2025 Earnings Call Transcript (Dec 2024, PDF): https://www.stockscans.in/document/f5d4pks3qke035gn3qywgq3a.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/t1dcjsca3x4ukdnx1xkq1mia.pdf
  • Q1 FY2025 Earnings Call Transcript (Jun 2024, PDF): https://www.stockscans.in/document/ym0emwfa3ki3u07diunxez37.pdf
  • Q4 FY2024 Earnings Call Transcript (Mar 2024, PDF): https://www.stockscans.in/document/kcuwkfy1yxj50hnnwkyeoefe.pdf
  • Q3 FY2024 Earnings Call Transcript (Dec 2023, PDF): https://www.stockscans.in/document/4c3msc08n7y5yeq5lu94n0jv.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/xa02cgbq1k6gh5nj3f8tv3k8.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/rgy4b01x99koe452x77grlyo.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/62yywfkdl5vt96ddv9r8juhb.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/z6fd4up5j5jbdnmpwihus0ns.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/u3sghpj4ky0n3j83y3987kjf.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/vk5j568ygbp1c7o6vone5cma.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/7mpqess3dwg7i6p0av2z2qut.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/qozzgrgh81erygk0ob0yjjpl.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/tb9x7ftyfxy72gt1ca6idsua.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/ycqnoieijtr2p4j6akgl2xzp.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/9o3bk43big9pd5nbwi9c6q84.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/q7t7yjkkii12o8x77olepnp5.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/fxe1fdk2u7wqgm0ns6zn8s66.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/pf4jfhsomc6gkshpsq2ybabl.pdf
  • Q1 FY2025 Investor Presentation (Jun 2024, PDF): https://www.stockscans.in/document/2ktd746q0n4zoi333upq1if9.pdf
  • Q4 FY2024 Investor Presentation (Mar 2024, PDF): https://www.stockscans.in/document/89cjb296ggh0lkq0auni564h.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/k71fszja0nhpixobhmdpsi4i.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/7drfifmqaoblau8a5wxajkal.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/sqjxr5loifw5phxllj7u8ft0.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/a5ehd0dwvrtjeob4e5rgsc37.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/43c75ix1es1aca9l67l7629v.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/d0z4yt1an7kenhljkl6vqnvq.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/n5qc2iw3w2zf3npn98tql745.pdf

Concall Transcript Summaries — Ganesh Benzoplast Ltd

  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3AGANESHBE/transcript-notes/202603/3q5m7ug5l7pgdg9otdc7xvgm.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3AGANESHBE/transcript-notes/202512/0mmwh22kqdygfmo6picojly4.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3AGANESHBE/transcript-notes/202509/5whvq86ja57bcf1t1zyu2xjg.pdf
  • Q3 FY2025 Concall Transcript Summary (Dec 2024): https://www.stockscans.in/company/NSE%3AGANESHBE/transcript-notes/202412/f5d4pks3qke035gn3qywgq3a.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3AGANESHBE/transcript-notes/202409/t1dcjsca3x4ukdnx1xkq1mia.pdf
  • Q1 FY2025 Concall Transcript Summary (Jun 2024): https://www.stockscans.in/company/NSE%3AGANESHBE/transcript-notes/202406/ym0emwfa3ki3u07diunxez37.pdf
  • Q4 FY2024 Concall Transcript Summary (Mar 2024): https://www.stockscans.in/company/NSE%3AGANESHBE/transcript-notes/202403/kcuwkfy1yxj50hnnwkyeoefe.pdf
  • Q3 FY2024 Concall Transcript Summary (Dec 2023): https://www.stockscans.in/company/NSE%3AGANESHBE/transcript-notes/202312/4c3msc08n7y5yeq5lu94n0jv.pdf